newsfilter
← Latest News
Business Wire·

Acadia Pharmaceuticals Announces Allowance of U.S. Patent Covering Weight-Banded Dosing of Trofinetide, extending U.S. patent protections to March 2041

-- The allowance strengthens the intellectual property portfolio for trofinetide and extends protections in the U.S. from July 2036 to March 2041 Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) today announced that the